Cardlytics (CDLX) Cash & Equivalents (2017 - 2026)

Cardlytics' Cash & Equivalents history runs 10 years deep, the most recent figure standing at $35.7 million for Q1 2026.

• Quarterly Cash & Equivalents fell 31.46% year-over-year to $35.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.7 million (down 31.46% YoY) and the FY2025 annual result came in at $48.7 million, down 25.73% from the prior year.
• Cash & Equivalents was $35.7 million for Q1 2026 at Cardlytics, down from $48.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $139.2 million in Q1 2023 and bottomed at $74000.0 in Q3 2022.
• A 5-year average of $62.6 million and a median of $65.6 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 99.97% — and 2023, when it jumped 151197.83%.
• Cardlytics' Cash & Equivalents stood at $121.9 million in 2022, then declined by 24.67% to $91.8 million in 2023, then slipped by 28.57% to $65.6 million in 2024, then declined by 25.73% to $48.7 million in 2025, then slipped by 26.78% to $35.7 million in 2026.
• Business Quant data shows CDLX's Cash & Equivalents at $35.7 million in Q1 2026, $48.7 million in Q4 2025, and $44.0 million in Q3 2025.